Franklin Huang, MD, PhD
Dr. Franklin Huang is an assistant professor at the University of California, San Francisco. His lab examines genetic differences between cancer cells and normal tissue, aiming to determine what makes certain tumors...Read More
Christopher Heaphy
Telomeres are repeating sequences of DNA located at the ends of chromosomes that act as a buffer to protect chromosomes from deterioration or abnormal fusions during DNA replication. Telomeres are...Read More
Leigh Ellis
Identification of molecular drivers of prostate cancer development and progression are critical for understanding prostate cancer biology and generating new treatments. Dr. Leigh Ellis is studying the role and therapeutic...Read More
Glenn Liu, MD
Developing a Novel Quantitative Total Bone Imaging (QTBI) Methodology to Assess Treatment Response in Metastatic Prostate Cancer The lack of ability to measure tumor response in bone has greatly hindered...Read More
Scott Tomlins
Dr. Tomlins earned a BA in Biology, from Willamette University in Salem, Oregon, a PhD in Molecular and Cellular Pathology from the University of Michigan, Ann Arbor, and is currently...Read More
Yuxi Zhang
The role of prostate cancer stem cell regulated by microRNA in the formation of androgen-independent prostate cancer Male hormones (androgens) fuel prostate cancer progression and the first line of treatment...Read More
David Ulmert
Development of 89Zr-5A10, a novel radiotracer to address AR signaling in advanced prostate cancer The androgen receptor (AR) signaling pathway is a key component in the progression of prostate cancer...Read More
Scott Tagawa
Dr. Tagawa earned a BS in Biology from Georgetown University and an MD degree from USC where he completed a Fellowship in Hematology and Oncology. He is currently an Assistant...Read More
Kit Lam, MD, PhD
Smart Nanoparticles for Imaging and Treatment of Prostate Cancer Dr. Lam is an expert in the area of nanotechnology drug delivery systems. His research group has invented a nanoparticle that...Read More
Christian R. Gomez, PhD
Hypoxia-Regulated DLG7 in Prostate Carcinogenesis and Prognosis An unmet medical need in prostate cancer diagnosis and therapy is the lack of highly-reliable progression biomarkers to monitor efficacy of therapy. Dr....Read More